5
Disclosures
Jan 26, 2026 — Feb 19, 2026
Date Range
GROWTH
Market Segment
Pharmaceutical
Sector

Disclosures

DateTypeHeadlinePDF
Feb 19 Other Veritas In Silico Announces New Board Members for March Meeting PDF
Feb 12 Corporate Action Veritas In Silico Sees Loss Widening Despite Revenue Gains in Dec 2025 Period PDF
Feb 12 Other Veritas In Silico Inc. Announces Business Plan PDF
Feb 12 Earnings Veritas In Silico Posts Losses Despite AI Platform Advances PDF
Jan 26 Other Veritas In Silico and SpiroChem Sign MOU for mRNA Target Compound Research PDF

Disclosure Types

Other: 3 Corporate Action: 1 Earnings: 1